Last 7 days
2.9%
Last 30 days
7.2%
Last 90 days
-10.9%
Trailing 12 Months
100%
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
BGNE | 292.3B | 1.4B | -8.63% | 14.28% | -145.87 | 206.43 | 20.37% | -37.45% |
ABBV | 282.2B | 58.1B | 2.64% | 1.09% | 23.85 | 4.86 | 3.30% | 2.55% |
REGN | 87.8B | 12.2B | 6.65% | 17.65% | 20.25 | 7.22 | -24.26% | -46.28% |
VRTX | 81.0B | 8.9B | 8.19% | 20.73% | 24.38 | 9.07 | 17.91% | 41.84% |
ALNY | 24.8B | 1.0B | 2.52% | 22.68% | -21.95 | 23.93 | 22.88% | -32.64% |
SRPT | 12.1B | 933.0M | -5.36% | 76.43% | -17.23 | 12.99 | 32.93% | -67.99% |
UTHR | 10.3B | 1.9B | -8.55% | 24.83% | 14.17 | 5.32 | 14.88% | 52.86% |
MID-CAP | ||||||||
MDGL | 4.4B | 504.0K | -13.23% | 146.90% | -14.85 | 2.5K | -66.53% | -22.12% |
RARE | 2.8B | 363.3M | -12.16% | -44.78% | -3.98 | 7.75 | 3.39% | -55.81% |
BPMC | 2.7B | 204.0M | 4.26% | -29.57% | -4.84 | 13.22 | 13.30% | 13.44% |
MRTX | 2.2B | 12.4M | -17.27% | -54.78% | -2.9 | 172.97 | - | -27.34% |
SMALL-CAP | ||||||||
CPRX | 1.7B | 214.2M | 7.24% | 100.00% | 21.01 | 8.15 | 52.10% | 110.42% |
MGNX | 442.4M | 151.9M | 15.09% | -18.62% | -3.69 | 2.91 | 96.19% | 40.75% |
CRBP | 30.3M | - | 159.64% | 1267.83% | -0.72 | 19.11 | -77.61% | 7.22% |
CYTK | 3.3M | 94.6M | -18.37% | -4.40% | -0.01 | 0.03 | 34.30% | -80.65% |
Income Statement (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Revenue | 11.7% | 214 | 192 | 170 | 154 | 141 |
Operating Expenses | 4.1% | 112 | 108 | 98.00 | 94.00 | 88.00 |
S&GA Expenses | 2.5% | 58.00 | 57.00 | 55.00 | 53.00 | 50.00 |
R&D Expenses | -4.3% | 20.00 | 21.00 | 17.00 | 17.00 | 17.00 |
EBITDA | 16.4% | 85.00 | 73.00 | 60.00 | 53.00 | - |
EBITDA Margin | 3.5% | 0.44* | 0.43* | 0.39* | 0.38* | - |
Earnings Before Taxes | 23.9% | 105 | 85.00 | 73.00 | 60.00 | 53.00 |
EBT Margin | 3.5% | 0.44* | 0.43* | 0.39* | 0.37* | - |
Net Income | 24.2% | 83.00 | 67.00 | 54.00 | 45.00 | 39.00 |
Net Income Margin | 9.2% | 0.35* | 0.32* | 0.29* | 0.28* | - |
Free Cahsflow | 26.2% | 95.00 | 75.00 | 64.00 | 59.00 | - |
Balance Sheet | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Assets | 12.8% | 376 | 333 | 267 | 247 | 238 |
Current Assets | 16.1% | 321 | 276 | 243 | 221 | 210 |
Cash Equivalents | 16.5% | 298 | 256 | 211 | 178 | 171 |
Inventory | -4.6% | 7.00 | 7.00 | 8.00 | 8.00 | 8.00 |
Net PPE | -4.0% | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Liabilities | 19.2% | 75.00 | 63.00 | 26.00 | 27.00 | 31.00 |
Current Liabilities | 28.9% | 58.00 | 45.00 | 22.00 | 23.00 | 27.00 |
Shareholder's Equity | 11.3% | 300 | 270 | 241 | 220 | 207 |
Retained Earnings | 104.4% | 50.00 | 24.00 | 2.00 | -15.62 | -26.31 |
Additional Paid-In Capital | 2.0% | 250 | 246 | 239 | 236 | 233 |
Accumulated Depreciation | 10.4% | 0.00 | 0.00 | 0.00 | 0.00 | - |
Shares Outstanding | 1.2% | 105 | 104 | 103 | 103 | 103 |
Cashflow (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Cashflow From Operations | 22.0% | 116 | 95.00 | 76.00 | 65.00 | 60.00 |
Share Based Compensation | 6.1% | 8.00 | 7.00 | 7.00 | 6.00 | 6.00 |
Cashflow From Investing | 2761.6% | 9.00 | -0.35 | -0.22 | -11.02 | - |
Cashflow From Financing | 154.9% | 2.00 | -3.08 | -9.17 | -9.88 | -8.14 |
Buy Backs | -31.0% | 7.00 | 10.00 | 15.00 | 14.00 | 12.00 |
90.8%
67.7%
65.4%
Y-axis is the maximum loss one would have experienced if Catalyst Pharmaceuticals was unfortunately bought at previous high price.
43.0%
45.5%
47.3%
62.7%
FIve years rolling returns for Catalyst Pharmaceuticals.
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-03-23 | MetLife Investment Management, LLC | reduced | -4.92 | 257,806 | 939,002 | 0.01% |
2023-03-15 | B. Riley Wealth Advisors, Inc. | new | - | 475,583 | 475,583 | 0.01% |
2023-03-10 | VICTORY CAPITAL MANAGEMENT INC | reduced | -19.96 | 753,423 | 5,448,420 | 0.01% |
2023-03-06 | Rockefeller Capital Management L.P. | reduced | -25.00 | - | 5,000 | -% |
2023-02-28 | Voya Investment Management LLC | reduced | -4.28 | 292,463 | 1,048,460 | -% |
2023-02-22 | TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY | unchanged | - | 172,000 | 555,000 | 0.01% |
2023-02-21 | MACQUARIE GROUP LTD | sold off | -100 | -2,424,000 | - | -% |
2023-02-21 | NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | added | 12,500 | 4,687 | 4,687 | -% |
2023-02-16 | GHP Investment Advisors, Inc. | unchanged | - | 7,320 | 22,320 | -% |
2023-02-15 | Steward Partners Investment Advisory, LLC | unchanged | - | 488 | 1,488 | -% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 14, 2023 | armistice capital, llc | 0% | 0 | SC 13G/A | |
Feb 10, 2023 | flynn james e | 5.65% | 5,884,448 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 6.50% | 6,768,741 | SC 13G | |
Feb 08, 2023 | state street corp | 7.57% | 7,873,314 | SC 13G/A | |
Jan 26, 2023 | blackrock inc. | 15.1% | 15,690,326 | SC 13G/A | |
Jan 20, 2023 | blackrock inc. | 15.1% | 15,690,326 | SC 13G/A | |
Nov 14, 2022 | flynn james e | 5.82% | 6,060,491 | SC 13G | |
Feb 15, 2022 | armistice capital, llc | 9.3% | 9,572,000 | SC 13G/A | |
Feb 09, 2022 | vanguard group inc | 4.69% | 4,836,313 | SC 13G/A | |
Feb 09, 2022 | state street corp | 4.90% | 5,050,989 | SC 13G/A |
Fair Value | Very Pessimistic | Pessimistic | Base Case | Optimistic | Very Optimistic |
---|---|---|---|---|---|
Very Low Inflation | 19.69 18.76% | 25.51 53.86% | 49.11 196.20% | 79.84 381.54% | 135.24 715.68% |
Current Inflation | 18.07 8.99% | 23.05 39.02% | 43.34 161.40% | 69.43 318.76% | 116.42 602.17% |
Very High Inflation | 16.05 -3.20% | 20.07 21.05% | 36.50 120.14% | 57.28 245.48% | 94.69 471.11% |
Date Filed | Form Type | Document | |
---|---|---|---|
Mar 31, 2023 | 8-K | Current Report | |
Mar 30, 2023 | 4 | Insider Trading | |
Mar 30, 2023 | 4 | Insider Trading | |
Mar 24, 2023 | 4 | Insider Trading | |
Mar 22, 2023 | 4 | Insider Trading | |
Mar 15, 2023 | 10-K | Annual Report | |
Mar 15, 2023 | 8-K | Current Report | |
Mar 07, 2023 | 8-K | Current Report | |
Feb 17, 2023 | 4 | Insider Trading | |
Feb 17, 2023 | 4 | Insider Trading |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-03-29 | Del Carmen Jeffrey | acquired | 127,063 | 3.17659 | 40,000 | chief commercial officer |
2023-03-29 | Del Carmen Jeffrey | sold | -667,810 | 16.6952 | -40,000 | chief commercial officer |
2023-03-29 | GRANDE ALICIA | sold | -835,100 | 16.702 | -50,000 | vp, treasurer and cfo |
2023-03-29 | GRANDE ALICIA | acquired | 56,500 | 1.13 | 50,000 | vp, treasurer and cfo |
2023-03-28 | GRANDE ALICIA | acquired | 45,990 | 0.79 | 58,216 | vp, treasurer and cfo |
2023-03-28 | GRANDE ALICIA | sold | -962,786 | 16.5382 | -58,216 | vp, treasurer and cfo |
2023-03-22 | GRANDE ALICIA | sold | -689,528 | 16.5022 | -41,784 | vp, treasurer and cfo |
2023-03-22 | GRANDE ALICIA | acquired | 33,009 | 0.79 | 41,784 | vp, treasurer and cfo |
2023-03-20 | Elsbernd Brian | sold | -803,450 | 16.069 | -50,000 | chief compliance/legal officer |
2023-03-20 | Elsbernd Brian | acquired | 56,500 | 1.13 | 50,000 | chief compliance/legal officer |
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME - USD ($) $ in Thousands | 12 Months Ended | ||
---|---|---|---|
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Revenues: | |||
Total revenues | $ 214,203 | $ 140,833 | $ 119,073 |
Operating costs and expenses: | |||
Cost of sales | 34,393 | 21,884 | 17,039 |
Research and development | 19,789 | 16,936 | 16,497 |
Selling, general and administrative | 58,183 | 49,628 | 44,234 |
Total operating costs and expenses | 112,365 | 88,448 | 77,770 |
Operating income | 101,838 | 52,385 | 41,303 |
Other income, net | 2,881 | 282 | 587 |
Net income before income taxes | 104,719 | 52,667 | 41,890 |
Income tax provision (benefit) | 21,640 | 13,185 | (33,093) |
Net income | $ 83,079 | $ 39,482 | $ 74,983 |
Net income per share: | |||
Basic | $ 0.8 | $ 0.38 | $ 0.72 |
Diluted | $ 0.75 | $ 0.37 | $ 0.71 |
Weighted average shares outstanding: | |||
Basic | 103,374,606 | 103,379,349 | 103,512,913 |
Diluted | 111,375,631 | 107,795,585 | 106,242,273 |
Net income | $ 83,079 | $ 39,482 | $ 74,983 |
Other comprehensive income: | |||
Unrealized gain (loss) on available-for-sale securities, net of tax of ($54), $46 and $0, respectively | 172 | (179) | 22 |
Comprehensive income | 83,251 | 39,303 | 75,005 |
Product revenue, net [Member] | |||
Revenues: | |||
Total revenues | 213,938 | 137,997 | 118,790 |
License and other revenue [Member] | |||
Revenues: | |||
Total revenues | $ 265 | $ 2,836 | $ 283 |
CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
---|---|---|
Current Assets: | ||
Cash and cash equivalents | $ 298,395 | $ 171,445 |
Short-term investments | 0 | 19,821 |
Accounts receivable, net | 10,439 | 6,619 |
Inventory | 6,805 | 7,870 |
Prepaid expenses and other current assets | 5,158 | 4,351 |
Total current assets | 320,797 | 210,106 |
Operating lease right-of-use asset | 2,770 | 3,017 |
Property and equipment, net | 847 | 959 |
License and acquired intangibles, net | 32,471 | |
Deferred tax assets, net | 18,736 | 23,697 |
Deposits | 9 | 9 |
Total assets | 375,630 | 237,788 |
Current Liabilities: | ||
Accounts payable | 3,975 | 2,768 |
Accrued expenses and other liabilities | 53,613 | 24,295 |
Total current liabilities | 57,588 | 27,063 |
Operating lease liability, net of current portion | 3,557 | 3,894 |
Other non-current liabilities | 14,064 | |
Total liabilities | 75,209 | 30,957 |
Commitments and contingencies (Note 12) | ||
Stockholders' equity: | ||
Preferred stock, $0.001 par value, 5,000,000 shares authorized: none issued and outstanding at December 31, 2022 and 2021 | 0 | 0 |
Common stock, $0.001 par value, 200,000,000 shares authorized; 105,263,031 shares and 102,992,913 shares issued and outstanding at December 31, 2022 and 2021, respectively | 105 | 103 |
Additional paid-in capital | 250,430 | 233,186 |
Retained earnings (accumulated deficit) | 49,862 | (26,310) |
Accumulated other comprehensive income (loss) | 24 | (148) |
Total stockholders' equity | 300,421 | 206,831 |
Total liabilities and stockholders' equity | $ 375,630 | $ 237,788 |